Pancreatitis associated with potassium bromide/phenobarbital combination therapy in epileptic dogs

In a retrospective study, at least 10% of dogs receiving potassium bromide/phenobarbital combination therapy, compared with 0.3% of dogs receiving phenobarbital monotherapy, had probable pancreatitis. Pancreatitis may be a more frequent and more serious adverse effect of potassium bromide/phenobarbital combination therapy than has been reported previously.LR: 20031114; PUBM: Print; JID: 0004653; 0 (Anticonvulsants); 0 (Bromides); 0 (Potassium Compounds); 50-06-6 (Phenobarbital); 7758-02-3 (potassium bromide); ppublishSource type: Electronic(1